This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

A Study of the Effectiveness of Virtual Reality Relaxation Combined With Patient-Controlled Analgesia (PCA) Morphine for Those Undergoing Burn Dressing Changes

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by Bayside Health.
Recruitment status was:  Recruiting
Information provided by:
Bayside Health Identifier:
First received: September 12, 2005
Last updated: March 14, 2007
Last verified: September 2005
The purpose of this study is to evaluate whether a sub-population of patients with burn injuries needing dressing changes respond to virtual reality (VR) utilising relaxation themes with improved pain and anxiety scores, when added to PCA morphine and background analgesic therapy.

Condition Intervention
Anxiety Pain Device: Virtual reality relaxation

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Predicting the Effectiveness of Virtual Reality Relaxation on Pain and Anxiety When Added to PCA Morphine in a Population of Burn Patients Having Dressing Changes

Resource links provided by NLM:

Further study details as provided by Bayside Health:

Primary Outcome Measures:
  • Association between hypnotic susceptibility and pain scores
  • Association between hypnotic susceptibility and anxiety scores

Secondary Outcome Measures:
  • Measurement of pain by visual analogue scale (VAS)
  • Measurement of anxiety by Burns Specific Anxiety Rating by VAS
  • Rating of hypnotic susceptibility and morphine use
  • Satisfaction rating
  • Morphine use
  • Incidence of side effects relating to morphine and VR

Estimated Enrollment: 90
Study Start Date: September 2004
  Show Detailed Description


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Burn injury
  • Scheduled for painful dressing changes
  • Conscious
  • Comprehension of PCA and virtual reality device
  • Comprehension of the English language

Exclusion Criteria:

  • Patient refusal
  • Psychotic disease
  • Paranoid disease
  • Unstable dissociative disorder
  • Borderline personality disorder
  • Phobias relevant to water/drowning
  • Epilepsy/propensity to fitting
  • Morphine allergy
  • Acute brain syndrome
  • Chronic brain syndrome
  • Physically unable to administer PCA
  • Severe burns involving the head
  • Visual impairment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00163917

Contact: Alex Konstantatos, MBBS, FANZCA 03 92763176 ext 3757
Contact: Margaret E Angliss, BN 03 92763176 ext 3757

Australia, Victoria
The Alfred Hospital Recruiting
Melbourne, Victoria, Australia, 3181
Contact: Alex Konstantatos, MBBS    03 92763176 ext 3757   
Principal Investigator: Alex Konstantatos, MBBS         
Sponsors and Collaborators
Bayside Health
Principal Investigator: Alex Konstantatos, MBBS The Alfred
  More Information Identifier: NCT00163917     History of Changes
Other Study ID Numbers: 107/ 04
Study First Received: September 12, 2005
Last Updated: March 14, 2007

Keywords provided by Bayside Health:

Additional relevant MeSH terms:
Analgesics, Opioid
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents processed this record on September 21, 2017